

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Adalimumab-adbm ni umuti usa n'uwa kinyamwimerere ufasha kuvura indwara ziterwa n'umubiri w'umuntu wanga ibyo witeye, ukagabanya imikorere y'umubiri w'umuntu w'ubwirinzi. Utekereze nk'ubuvuzi bugamije guhagarika proteyine zihindura umubiri, bigatuma umubiri w'umuntu ubyimba, bigatanga ubufasha ku ndwara nka rheumatoid arthritis, psoriasis, na inflammatory bowel disease.
Uyu muti ubarirwa mu cyiciro cy'imiti yitwa TNF blockers, ikora ihagarika tumor necrosis factor-alpha, proteyine itera umubiri kubyimba. Iyo umubiri w'umuntu w'ubwirinzi witiranya ibice by'umubiri bifite ubuzima bwiza, adalimumab-adbm irinjira kugira ngo igarure uburinganire kandi igabanye ibimenyetso bibabaza.
Adalimumab-adbm ni verisiyo isa n'iya kinyamwimerere y'umuti wa adalimumab, yateguwe kugira ngo ikore neza kimwe ariko akenshi ku giciro gito. Biosimilar ni verisiyo isa cyane n'umuti wa kinyabuzima wemewe, wagenzurwa cyane kugira ngo wemeze ko utanga inyungu zimwe za therapeutic.
Uyu muti ni monoclonal antibody, bivuze ko ari proteyine yakozwe muri laboratwari yigana imikorere y'umubiri w'umuntu w'ubwirinzi. Igice cya "adbm" ni inyongera yoroshya gutandukanya uyu muti wihariye n'abandi bo mu muryango umwe.
Uzakira uyu muti binyuze mu nshinge ya subcutaneous, bivuze ko ijya munsi y'uruhu rwawe aho kujya mu mutsi cyangwa mu maraso. Ubu buryo butuma umuti winjira gahoro kandi butuma abarwayi benshi bashobora kwifata iwabo nyuma yo kubona imyitozo ikwiye.
Adalimumab-adbm ivura indwara nyinshi ziterwa n'umubiri w'umuntu wanga ibyo witeye aho umubiri wawe w'ubwirinzi witiranya ibice byawe bifite ubuzima bwiza. Muganga wawe ashobora kugusaba uyu muti iyo izindi nshuti zitatanze ubufasha buhagije cyangwa iyo ukeneye uburyo bukomeye bwo gucunga ibimenyetso byawe.
Indwara zisanzwe zivurwa zirimo indwara ya rheumatoid arthritis, aho ifasha kugabanya ububabare bwo mu ngingo no kubyimba mugihe ikumira kwangirika kw'ingingo mu gihe kirekire. Abarwayi benshi babona impinduka zigaragara mu bikorwa byabo bya buri munsi ndetse no mu mibereho yabo yose.
Dore indwara z'ingenzi uyu muti ushobora gufasha kuvura:
Indwara zose zisubiza mu buryo butandukanye ku buvuzi, kandi muganga wawe azakurikiza imikorere yawe yitonze kugirango yemeze ko urimo kubona inyungu nyinshi hamwe n'ingaruka nke.
Adalimumab-adbm ikora ibuza TNF-alpha, poroteyine ikora nk'intumwa ibwira umubiri wawe w'ubudahangarwa gukora umuvumo. Iyo ufite indwara y'ubudahangarwa, umubiri wawe ukora TNF-alpha nyinshi cyane, bigatuma umuvumo uhoraho no kwangirika kw'imitsi.
Uyu muti ufatwa nk'ubuvuzi bukomeye, bugamije guhagarika by'umwihariko inzira y'umuvumo aho guhagarika umubiri wawe wose w'ubudahangarwa. Mu kwifatanya na TNF-alpha, birinda iyi poroteyine kwifatanya n'uturemangingo no gutera umuvumo.
Ingaruka ntizihita zigaragara - abantu benshi batangira kubona impinduka mu byumweru 2-4, hamwe n'inyungu nyinshi zigaragara nyuma y'amezi 3-6 yo kuvurwa buri gihe. Umubiri wawe ukeneye igihe cyo kugabanya umuvumo uriho no gutangira gukiza imitsi yangiritse.
Adalimumab-adbm itangwa nk'urushinge rwo munsi y'uruhu, bivuze ko urushinge rugera munsi y'uruhu rwawe, kimwe n'uko abantu barwaye diyabete batera insuline. Umuganga wawe azakwigisha uburyo bukwiye, cyangwa umwe mu muryango ashobora kwiga kugufasha.
Aho inshinge ziterwa akenshi zisimburana hagati y'ikibero cyawe n'inda, wirinda ahantu hakomeretse, hakomeretse cyangwa hari ibikomere. Ukeneye kureka umuti ukagera ku bushyuhe busanzwe mbere yo kuwutera, kuko ibi bigabanya kutagira umunezero.
Abantu benshi batera inshinge buri byumweru bibiri, nubwo muganga wawe ashobora guhindura iyi gahunda bitewe n'uburwayi bwawe bwihariye n'uburyo ubwitabira. Ni ngombwa gukurikiza gahunda yawe yategetswe, kuko urwego rwa buri gihe rw'umuti mu mubiri wawe rutanga umusaruro mwiza.
Ntabwo ukeneye gufata uyu muti hamwe n'ibiryo, ariko kugumana imirire myiza birashobora gushyigikira intsinzi yawe y'ubuvuzi muri rusange. Abantu bamwe babona ko bifasha gutera inshinge mu gihe kimwe buri cyumweru kugirango bashyireho gahunda.
Igihe cyo kuvurwa na adalimumab-adbm gitandukanye cyane bitewe n'uburwayi bwawe n'uburyo ubwitabira umuti. Abantu benshi bafite indwara zidakira ziterwa n'umubiri bakoresha uyu muti imyaka myinshi kugirango bagumane ibimenyetso byo kugenzura no kwirinda iterambere ry'indwara.
Muganga wawe azagenzura buri gihe iterambere ryawe binyuze mu igeragezwa ry'amaraso, ibizamini by'umubiri, n'ibiganiro ku bijyanye n'ibimenyetso byawe. Niba ukora neza, gukomeza kuvurwa akenshi birinda ibibazo no kurinda ingorane zirambye.
Abantu bamwe bashobora kugabanya urugero rwabo cyangwa kongera igihe hagati y'inshinge igihe ubuzima bwabo bugenzurwa neza. Ariko, guhagarara ako kanya nta kuyoborwa n'abaganga birashobora gutuma ibimenyetso bigaruka, bityo impinduka zose zigomba kujyanwa n'abaganga bawe.
Intego ni ukubona uburinganire bukwiye hagati yo kugenzura uburwayi bwawe no kugabanya ingaruka zirambye zishobora guterwa n'umuti.
Kimwe n'imiti yose, adalimumab-adbm ishobora gutera ingaruka zidakunzwe, nubwo abantu benshi bayihanganira neza. Ingaruka zikunze kugaragara akenshi ziba zoroshye kandi zishobora kwitabwaho, naho ingaruka zikomeye zikaba zitagaragara kenshi ariko zigasaba ubufasha bwihuse bw'abaganga.
Kumenya ibyo witegura bishobora kugufasha kumva ufite icyizere ku bijyanye n'imiti yawe kandi ukamenya igihe cyo kuvugana n'umuganga wawe.
Ingaruka zisanzwe ushobora guhura nazo zirimo:
Ibi bimenyetso akenshi biragenda bikosoka uko umubiri wawe wimenyereza umuti, akenshi mu mezi make ya mbere yo kuvurwa.
Ingaruka zikomeye zisaba ubufasha bwihuse bw'abaganga zirimo:
Muganga wawe azakugenzura neza kuri izi ngaruka binyuze mu gusuzuma buri gihe no gupima amaraso, cyane cyane mu mezi make ya mbere yo kuvurwa.
Indwara zitagaragara ariko zikomeye zishobora kwigaragaza rimwe na rimwe, zirimo ubwoko runaka bwa kanseri, indwara zikomeye, cyangwa kongera gukora kw'indwara zihishe nka igituntu. Umuganga wawe azasuzuma ibi byago mbere yo gutangira kuvura kandi akomeze kugenzura mu gihe cyose uvurwa.
Adalimumab-adbm ntibagenewe buri wese, kandi muganga wawe azasuzuma neza niba bikwiriye kuri wowe bitewe n'amateka yawe y'ubuzima n'ubuzima bwawe ubu. Ibyiciro bimwe na bimwe cyangwa ibihe bituma uyu muti ushobora kuba mubi aho kuba ingirakamaro.
Ntabwo ukwiye gufata uyu muti niba ufite icyorezo gikora, kuko gishobora gukumira ubushobozi bwa sisitemu yawe y'ubudahangarwa bwo kurwanya bagiteri, virusi, cyangwa imyungu. Ibi birimo indwara zigaragara n'izihishe zitari zikigaragaza ibimenyetso.
Abantu bafite ibi bikurikira ntibashobora gufata adalimumab-adbm:
Muganga wawe azakoresha kandi ubushishozi niba ufite diyabete, COPD, cyangwa izindi ndwara zigira ingaruka ku mikorere y'ubudahangarwa bwawe, kuko ibi bishobora kongera ibyago byo guhura n'ibibazo.
Kutwita no konsa bisaba kwitonderwa byihariye, kuko umuti ushobora kwambuka placenta kandi ugashobora kugira ingaruka ku mwana ukura. Muganga wawe azagereranya inyungu n'ibyago bishoboka muri ibi bihe.
Adalimumab-adbm iboneka munsi y'izina ry'ubwoko bwa Cyltezo, ikorwa na Boehringer Ingelheim. Uyu muti wemewe na FDA nk'ubundi buryo bufite igiciro gito cyo gusimbuza umuti wa mbere wa adalimumab.
Farumasi yawe ishobora kandi kuwita izina ryayo risanzwe ryuzuye, adalimumab-adbm, bifasha gutandukanya n'izindi adalimumab biosimilars zifite inyuguti zitandukanye zinyongera. Umuti ubwawo ukora kimwe nubwo izina ririho ku cyapa cyawe cyo kwandikisha.
Ubwishingizi bushobora gutandukana hagati y’ibicuruzwa bitandukanye bya adalimumab, bityo muganga wawe n’umufarumasiti bazakorana kugira ngo barebe ko ubona uburyo buhendutse kandi bujyanye n’ibyo ukeneye kuvurwa.
Imiti myinshi isimbura ikora kimwe na adalimumab-adbm mu kugabanya ibice bitandukanye by’umubiri birwanya indwara. Muganga wawe ashobora gutekereza izi nzira niba utitabira neza adalimumab cyangwa ukagira ingaruka zikomeye zituma itagukwiriye.
Izindi miti ikora nka TNF harimo etanercept, infliximab, na certolizumab, buri imwe ifite uburyo butandukanye bwo kuyikoresha n’ingaruka zayo. Abantu bamwe bitwara neza iyo bakoresheje imiti ya TNF kurusha iyindi, bityo kuyihinduranya rimwe na rimwe bishobora guteza imbere ibisubizo.
Imiti itari iya TNF itanga uburyo butandukanye bwo gukora kandi harimo imiti nka rituximab, abatacept, na tocilizumab. Iyi miti igamije proteyine zitandukanye z’umubiri zirwanya indwara kandi zishobora kugira akamaro iyo imiti ya TNF itatanga ubufasha buhagije.
Imiti ya kera nka methotrexate, sulfasalazine, na corticosteroids zigifite akamaro mu kuvura, akenshi zikoreshwa hamwe n’imiti ikora mu mubiri cyangwa nk’ubuvuzi bwonyine ku bantu barwaye indwara zoroheje.
Adalimumab-adbm na Humira birimo ibintu bikora kimwe kandi bikora kimwe mu kuvura indwara ziterwa n’umubiri wirwanya. Itandukaniro rikuru ni uko adalimumab-adbm ari biosimilar, bivuze ko ari verisiyo isa cyane na Humira yageragejwe kugira ngo yemeze ko ifite ubushobozi bungana n’ubw’umutekano.
Ubushakashatsi bwa kliniki bwerekana ko adalimumab-adbm itanga ibisubizo bimwe byo kuvura nka Humira, nta tandukaniro rikomeye mu buryo igenzura ibimenyetso cyangwa rikabuza indwara gukomeza. Imiti yombi ifite ingaruka zisa kandi bisaba gukurikiranwa kimwe.
Inyungu ya mbere ya adalimumab-adbm akenshi ni ikiguzi, kuko imiti isa n'iyo y'umwimerere akenshi igura make ugereranyije n'umuti w'umwimerere. Ibi bishobora koroshya uburyo bwo kuvurwa kandi bikagabanya amafaranga usohora mu mufuka wawe, cyane cyane niba ukeneye kuvurwa igihe kirekire.
Muganga wawe azahitamo hagati y'ibi bintu bitewe n'ubwishingizi bwawe, icyo ukunda, n'uko biboneka, azi ko byombi bizatanga inyungu zingana mu buvuzi.
Adalimumab-adbm bisaba ko ubitekerezaho neza niba ufite indwara z'umutima, cyane cyane umutima utagikora neza. Uyu muti ushobora gutuma ibimenyetso by'umutima utagikora neza birushaho mu bantu bamwe, cyane cyane abafite ibibazo by'umutima bikomeye.
Muganga wawe azasuzuma neza ubuzima bw'umutima wawe mbere yo kugusaba uyu muti, ashobora gukoresha icyuma gipima umutima cyangwa izindi nyigo z'umutima. Niba ufite ibibazo by'umutima bito, ushobora gukomeza gufata adalimumab-adbm ariko ukagenzurwa neza.
Bwira muganga wawe ako kanya niba ugize ibimenyetso bishya cyangwa bikomeye nk'umwuka mubi, kubyimba amaguru, cyangwa kuribwa mu gituza mugihe ufata uyu muti.
Niba witereye adalimumab-adbm nyinshi kuruta uko byategetswe, vugana n'umuganga wawe ako kanya kugira ngo akugire inama. Nubwo kwifashisha imiti myinshi bidakunze kubaho kuri uyu muti, gufata nyinshi bishobora kongera ibyago byo kugira ingaruka zikomeye, cyane cyane indwara zandura.
Ntugategereze ngo urebe niba ugira ibimenyetso – hamagara muganga wawe ako kanya, kabone niyo wumva umeze neza. Bashobora kwifuza kugukurikiranira hafi ibimenyetso by'indwara zandura cyangwa izindi ngorane mu byumweru bike biri imbere.
Bika imiti yose hamwe n'ibipaki byayo kandi wandike neza umubare w'inyongera wafashe, kuko iyi makuru izafasha umuganga wawe kumenya uburyo bwiza bwo gukora.
Niba usize urugero rwa adalimumab-adbm, urufate uko wibukije, keretse igihe cyegereye urugero rwawe ruteganyijwe. Muri urwo rubanza, reka urugero wasize, hanyuma usubire ku gahunda yawe isanzwe – ntukongereho urugero.
Kusiba urugero rimwe na rimwe ntizatera ingaruka zihuse, ariko gukomeza ni ngombwa kugira ngo urugero rw'umuti rugume mu mubiri wawe. Gerageza gushyiraho ibyibutsa kuri terefone yawe cyangwa ukore ibimenyetso ku minsi yo guterwa inshinge kuri kalendari yawe.
Niba ukunda kwibagirwa urugero, ganira na muganga wawe ku bijyanye n'uburyo bwo kugufasha kwibuka, nk'uko guhuza n'indi miti cyangwa ibikorwa byawe bisanzwe.
Ntuzigere uhagarika gufata adalimumab-adbm utabanje kubiganiraho na muganga wawe, kabone n'iyo wumva umeze neza cyane. Guhagarika ako kanya bishobora gutuma ibimenyetso byawe bisubira, rimwe na rimwe bikaba bikomeye kurusha mbere yo gutangira kuvurwa.
Muganga wawe azagufasha kumenya niba kandi igihe bikwiye kugabanya urugero rwawe cyangwa guhagarika umuti rwose. Iyi myanzuro ishingiye ku buryo uburwayi bwawe bugenzurwa neza, igihe umaze mu gihe cyo gukira, n'akaga ko kongera kurwara.
Abantu bamwe bashobora gukuraho umuti nyuma y'imyaka yo gukira neza, mu gihe abandi bakeneye gukomeza kuvurwa igihe kirekire kugira ngo birinde ko indwara ikomeza. Imiterere yawe bwite izayobora iyi myanzuro y'ingenzi.
Ntugomba guhabwa inkingo zikora mugihe ufata adalimumab-adbm, kuko ubudahangarwa bwawe bwashyizwe hasi bushobora kutabasha kuzifata neza. Inkingo zikora zirimo umusonga, amashaza, rubella, varicella (chickenpox), n'inkingo z'ibicurane zinyuzwa mu mazuru.
Ariko, urashobora kandi ugomba guhabwa inkingo zitagira ubuzima, nk'urukingo rwa grip, urukingo rwa pneumoniya, n'inkingo za COVID-19. Izi ni ingenzi cyane kuko ubudahangarwa bwawe bugabanuka gato n'imiti.
Buri gihe bwire umuganga wese uvura ibyerekeye imiti yawe ya adalimumab-adbm mbere yo guhabwa inkingo, kandi gerageza kubona inkingo ziteganijwe mbere yo gutangira iyi miti niba bishoboka.
Get clear medical guidance
on symptoms, medications, and lab reports.